The IMF’s Understanding series of cancer information booklets is designed to acquaint you with specific multiple myeloma-related tests, treatments and therapies, supportive care measures, and common adverse events.
April 15, 2021
This publication discusses the use of Revlimid (lenalidomide)—an immunomodulatory drug (IMiD)—for the treatment of myeloma.
April 13, 2020
The Understanding SARCLISA® (isatuximab-irfc) booklet discusses a novel anti-CD38 monoclonal antibody that is approved for patients with relapsed and…
July 31, 2018
This publication discusses the use of Thalomid (Thalidomide)—an immunomodulatory drug (IMiD)—for the treatment of myeloma.
March 01, 2022
This publication discusses the effects of myeloma on the immune system.
March 31, 2022
The Understanding the VRd Regimen booklet discusses a combination therapy for treating newly diagnosed myeloma that consists of three drugs
We Thank Our Sponsors:
BMS, Janssen, Karyopharm Therapeutics, and Takeda Oncology